JPH04124118A - Skin external preparation - Google Patents
Skin external preparationInfo
- Publication number
- JPH04124118A JPH04124118A JP24518590A JP24518590A JPH04124118A JP H04124118 A JPH04124118 A JP H04124118A JP 24518590 A JP24518590 A JP 24518590A JP 24518590 A JP24518590 A JP 24518590A JP H04124118 A JPH04124118 A JP H04124118A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- erythritol
- acid
- external preparation
- epsilon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 28
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 28
- 239000004386 Erythritol Substances 0.000 claims abstract description 27
- 229940009714 erythritol Drugs 0.000 claims abstract description 27
- 235000019414 erythritol Nutrition 0.000 claims abstract description 27
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960002684 aminocaproic acid Drugs 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 206010015150 Erythema Diseases 0.000 abstract description 7
- 231100000321 erythema Toxicity 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 239000000839 emulsion Substances 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 4
- 150000005846 sugar alcohols Chemical class 0.000 abstract description 4
- 206010040880 Skin irritation Diseases 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 231100000475 skin irritation Toxicity 0.000 abstract description 3
- 230000036556 skin irritation Effects 0.000 abstract description 3
- 241000221198 Basidiomycota Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract 2
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 150000003538 tetroses Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- -1 polyoxyethylene Polymers 0.000 description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 10
- 229960005150 glycerol Drugs 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000004166 Lanolin Substances 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229940039717 lanolin Drugs 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010033733 Papule Diseases 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000000845 maltitol Substances 0.000 description 4
- 235000010449 maltitol Nutrition 0.000 description 4
- 229940035436 maltitol Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- FMOUWNBVUJNNHE-XXAVUKJNSA-N CC(O)CO.OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound CC(O)CO.OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O FMOUWNBVUJNNHE-XXAVUKJNSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- JVGZXCCKUMXEOU-UHFFFAOYSA-N 7-aminoazepan-2-one Chemical compound NC1CCCCC(=O)N1 JVGZXCCKUMXEOU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000189123 Rumex japonicus Species 0.000 description 1
- 235000005247 Rumex japonicus Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 241001622901 Scomberomorus commerson Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は肌荒れを改善し、皮膚に潤いと艶を与える効果
に優れ、丘疹、面庖、llI庖、紅斑などを発生させな
い、安全性に優れた皮膚外用剤に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention improves rough skin, has an excellent effect of providing moisture and luster to the skin, does not cause papules, acne scars, erythema, etc., and is safe. Concerning excellent external skin preparations.
[従来の技術]
化粧品等の皮膚外用剤の大きな目的の一つに肌荒れ防止
、改善がある。この目的を達成するために従来はグリセ
リン、ソルビトール、プロピレングリコール、多糖等の
各種保湿剤を配合することか行われてきた。[Prior Art] One of the major purposes of external skin preparations such as cosmetics is to prevent and improve skin roughness. In order to achieve this purpose, various moisturizing agents such as glycerin, sorbitol, propylene glycol, and polysaccharide have been blended into the composition.
[発明か解決しようとする課題]
しかしながら、保湿剤、例えば多糖はアルコールの多い
処方系で沈澱を生じ、グリセリン、ソルビトール、プロ
ピレングリコールやコンドロイチン硫酸等は多量に配合
するとべたついたり、はてり感があり、また、DL−ス
レオニン等のアミノ酸では、着色、変臭などの欠点を有
していた。ざらに、最も汎用される保湿剤であるグリセ
リン、プロピレングリコールでは、多量に配合すると丘
疹、面庖、fA庖、紅斑など製品の皮膚クレームの原因
となることが、近年、知られるようになった。[Problem to be solved by the invention] However, moisturizers, such as polysaccharides, may precipitate if formulated with a high alcohol content, and glycerin, sorbitol, propylene glycol, chondroitin sulfate, etc. may become sticky or give a sticky feeling when added in large amounts. However, amino acids such as DL-threonine have disadvantages such as coloring and odor. In recent years, it has become known that the most commonly used moisturizers, glycerin and propylene glycol, can cause skin complaints such as papules, acne, fading, and erythema when used in large amounts. .
本発明者らは、上記事情に鑑み、鋭意研究を重ねた結果
、エリスリトールを配合した皮膚外用剤が肌荒れ防止、
改善に優れているばかりでなく、グリセリン、ソルビト
ールなど他の多価アルコールに見られるべたつき感や丘
疹、面庖、製電、紅斑などの発生が少ないことを見出し
、また、エリスリトールとイプシロンアミノカプロン酸
を共に配合した皮膚外用剤はこれらの作用かより強くな
ることを見出し、本発明を完成するに至った。In view of the above circumstances, the present inventors have conducted extensive research and found that a topical skin preparation containing erythritol can prevent rough skin and
We found that erythritol and epsilon aminocaproic acid were not only effective in improving symptoms, but were also less likely to cause the sticky feeling, papules, acne, erythema, etc. seen with other polyhydric alcohols such as glycerin and sorbitol. It was discovered that these effects are even stronger when the external skin preparations are formulated with the above ingredients, and the present invention has been completed.
[課題を解決するための手段1
すなわち、本発明は、エリスリト−ルを配合することを
持竜とする皮膚外用剤、およびエリスリトールとイプシ
ロンアミノカプロン酸とを配合することを特徴とする皮
膚外用剤である。[Means for Solving the Problems 1] That is, the present invention provides an external skin preparation which is characterized by containing erythritol, and a skin external preparation which is characterized by containing erythritol and epsilon aminocaproic acid. be.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられるエリスリトールはメソ−エリスリト
ールとも呼ばれ、天然界では地衣、担子菌、果実などに
含まれる4単糖の糖アルコールである。Erythritol used in the present invention is also called meso-erythritol, and is a tetramonosaccharide sugar alcohol that is naturally found in lichens, basidiomycetes, fruits, and the like.
本発明におけるエリスリトールの配合量は皮膚外用剤中
の0.1〜30重量%が好ましく、ざらに好ましくは1
〜20重量%である。0.1%未満では本発明の効果を
発揮しに<<、30%を超えて配合しても効果の増大は
期待できない。The amount of erythritol in the present invention is preferably 0.1 to 30% by weight, more preferably 1% by weight in the skin external preparation.
~20% by weight. If it is less than 0.1%, the effect of the present invention will not be exhibited, and even if it is added in excess of 30%, no increase in the effect can be expected.
また、本発明に用いられるイプシロンアミノカプロン酸
はイプシロンアミノカプロラクタムとも呼ばれ、イプシ
ロンアミノ酸の一種である。Furthermore, epsilon aminocaproic acid used in the present invention is also called epsilon aminocaprolactam, and is a type of epsilon amino acid.
本発明におけるイプシロンアミノカプロン酸の配合量は
皮膚外用剤中の0.1〜30重量%か好ましく、ざらに
好ましくは1〜20重量%である。 0゜1%未満では
本発明の効果を発揮しに< < 、30%を超えて配合
しても効果の増大は期待できない。The amount of epsilon aminocaproic acid in the present invention is preferably 0.1 to 30% by weight, more preferably 1 to 20% by weight in the external skin preparation. If it is less than 0.1%, the effect of the present invention will not be exhibited, but if it is added in excess of 30%, no increase in the effect can be expected.
エリスリトールは単独で配合しても効果があるが、イプ
シロンアミノカプロン酸と組合せることにより、相乗的
な効果の増大が期待できる。Erythritol is effective even when blended alone, but an increased synergistic effect can be expected by combining it with epsilon aminocaproic acid.
本発明の皮膚外用剤は化粧料、医薬品、医薬部外品等、
外皮に適用されるものを指し、従って、その剤型も水溶
液系、可溶化系、乳化系、粉末系、油液系、ゲル系、軟
膏系、水−油2層系、水−油一粉末3層系等、幅広い形
態を取り得る。The skin external preparation of the present invention can be used for cosmetics, pharmaceuticals, quasi-drugs, etc.
This refers to products that are applied to the outer skin, and therefore, its dosage forms include aqueous solutions, solubilized systems, emulsified systems, powder systems, oil liquid systems, gel systems, ointment systems, water-oil two-layer systems, and water-oil-powder systems. It can take a wide range of forms, such as a three-layer system.
本発明の皮膚外用剤には、上記必須成分の他に通常、化
粧料や医薬品等の皮膚外用剤に用いられる他の成分、例
えば、二酸化チタン、マイカ、タルク等の粉末成分、ア
ボガト油、マカデミアナツツ油、トウモロコシ油、オリ
ーブ油、ナタネ油、月見草油、ヒマシ油、ヒマワリ油、
茶実油、コメヌカ油、ホホバ油、カカオ脂、ヤシ油、ス
クワレン、スクワラン、牛脂、モクロウ、ミツロウ、キ
ャンテ′リラロウ、カルナバロウ、鯨ロウ、ラノリン、
シリコン油、流動パラフィン、セレシン、ワセリン、ポ
リオキシエチレン(8モル)オレイルアルコールエーテ
ル、モノオレイン酸グリセリル等の油分、カプリルアル
コール、ラウリルアルコール、ミリスチルアルコール、
セチルアルコール、コレステロール、フィトステロール
等の高級アルコール、カプリン酸、ラウリン酸、ミリス
チン酸、パルミチン酸、ステアリン酸、へベニン酸、ラ
ノリン脂肪酸、リノール酸、リルン酸等の高級脂肪酸、
パラアミノ安息香酸、ホモメンチル−7N−アセチルア
ラントラニレート、ブチルメトキシベンゾイルメタン、
ジーパラメトキシケイヒ酸−モノー2−エチルヘキサン
酸グリセリル、アミルサリシレート、オクチルシンナメ
ート、2.4−ジヒドロキシベンゾフェノン等の紫外線
吸収剤、ポリエチレングリコール、グリセリン、ソルビ
トール、キシリトール、マルチトール、ムコ多糖、ヒア
ルロン酸、コンドロイチン硫酸、キトサン等の保湿剤、
メチルセルロース、エチルセルロース、アラビアガム、
ポリビニルアルコール、モンモリロナイト、ラポナイト
等の増結剤、エタノール、■、3、−ブチレングリコー
ル等の有機溶剤、ブチルヒドロキシトルエン、トコフェ
ロール、フィチン酸等の酸化防止剤、安息香酸、サリチ
ル酸、ソルビン酸、パラオキシ安息香酸アルキルエステ
ル(エチルパラベン、ブチルパラベン等)、ヘキサクロ
ロフェン等の抗菌防腐剤、グリシン、アラニン、バリン
、ロイシン、セリン、トレオニン、フェニルアラニン、
チロシン、アスパラギン酸、アスパラギン、グルタミン
、タウリン、アルギニン、ヒスチジン等のアミノ酸及び
これらのアルカリ金属塩と塩酸塩、アシルサルコシン酸
(例えばラウロイルコシンナトリウム)、グルタチオン
、クエン酸、リンゴ酸、酒石酸、乳酸等の有機酸、ビタ
ミンA及びその誘導体、ビタミンB6塩酸塩、ビタミン
B61−リパルミテート、ビタミンB6ジオクタノエー
ト、ビタミンB2及びその誘導体、ビタミンB12、ビ
タミンB10及びその誘導体等のビタミンB類、アスコ
ルビン酸、アスコルビン酸硫酸エステル(塩)、アスコ
ルビン酸リン酸エステル(塩)、アスコルビン酸ジパル
ミテート等のビタミンC類、α−トコフェロール、β−
トコフェロール、γ−トコフェロール、ビタミンEアセ
テート、ビタミンEニコチネート等のビタミンE類、ビ
タミンD類、ビタミンH1パントテン酸、パンテチン等
のビタミン類、ニコチン酸アミド、ニコチン酸ベンジル
、γ−オリザノール、アラントイン、グリチルリチン酸
(塩)、グリチルレチン酸及びその誘導体、ヒノキチオ
ール、ムシジン、ビサボロール、ユーカリブトール、チ
モール、イノシトール、サポニン類(サイコサポニン、
ニンジンサポニン、ヘチマサボニン、ムクロジサポニン
等)、パントテニルエチルエーテル、エチニルエストラ
ジオール、トラネキサム酸、セファランチン、プラセン
タエキス等の各種薬剤、ギシギシ、クララ、コウホネ、
オレンジ、セージ、ノコギリソウ、ゼニアオイ、センキ
コウ、センブリ、タイム、トウキ、トウヒ、バーチ、ス
ギナ、ヘチマ、マロニエ、ユキノシタ、アル二カ、ユリ
、ヨモギ、シャクヤク、アロエ、クチナシ、サワラ等の
有機溶媒、アルコール、多価アルコール、水、水性アル
コール等で抽出した天然エキス、色素、モノラウリン酸
ソルビタン、モノパルミヂン酸ソルビタン、セスキオレ
イン酸ソルビタン、トJ)オレイン酸ソルビタン、モノ
ラウリン酸ポリオキシエチレンソルビタン、モノステア
リン酸ポリオキシエチレンソルビタン、ポリエチレング
リコールモノオレート、ポリオキシエチレンアルキルエ
ーテル、ポリグリコールジエステル、ラウロイルジェタ
ノールアマイド、脂肪酸イソプロパツールアマイド、マ
ルチトールヒドロキシ脂肪族エーテル、アルキル化多糖
、アルキルグルコシド、シュガーエステル等の非イオン
界面活性剤、ステアリルトリメチルアンモニウムクロラ
イド、塩化ベンザルコニウム、ラウリルアミンオキサイ
ド等のカチオン界面活性剤、パルミチン酸ナトリウム、
ラウリン酸ナトリウム、ラウリル硫酸ナトリウム、ラウ
リル硫酸カリウム、アルキル硫酸トリエタノールアミン
エーテル、ロート油、リニアドデシルベンゼン硫酸、ポ
リオキシエチレン硬化ヒマシ油マレイン酸、アシルメチ
ルタウリン等のアニオン界面活性剤、両性界面活性剤、
香料、精製水等を配合することができる。また、本発明
の剤型は、任意であり、例えば化粧水などの可溶化系、
乳液、クリーム等の乳化系あるいはファンデーション、
分散系、軟膏などの剤型をとることができる。In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may contain other ingredients normally used in external skin preparations such as cosmetics and pharmaceuticals, such as powder components such as titanium dioxide, mica, and talc, avocado oil, and macadamia. Nut oil, corn oil, olive oil, rapeseed oil, evening primrose oil, castor oil, sunflower oil,
Tea seed oil, rice bran oil, jojoba oil, cacao butter, coconut oil, squalene, squalane, beef tallow, Japanese wax, beeswax, cante'lira wax, carnauba wax, spermaceti wax, lanolin,
Oils such as silicone oil, liquid paraffin, ceresin, vaseline, polyoxyethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, caprylic alcohol, lauryl alcohol, myristyl alcohol,
Higher alcohols such as cetyl alcohol, cholesterol, and phytosterols; higher fatty acids such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, hebenic acid, lanolin fatty acid, linoleic acid, and lilunic acid;
Para-aminobenzoic acid, homomenthyl-7N-acetyl alanthranilate, butylmethoxybenzoylmethane,
UV absorbers such as di-paramethoxycinnamate-mono-2-ethylhexanoic acid glyceryl, amyl salicylate, octyl cinnamate, 2,4-dihydroxybenzophenone, polyethylene glycol, glycerin, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, Humectants such as chondroitin sulfate and chitosan,
Methylcellulose, ethylcellulose, gum arabic,
Bulking agents such as polyvinyl alcohol, montmorillonite, and laponite, organic solvents such as ethanol, ■,3,-butylene glycol, butylated hydroxytoluene, tocopherol, antioxidants such as phytic acid, benzoic acid, salicylic acid, sorbic acid, and paraoxybenzoic acid. Alkyl esters (ethylparaben, butylparaben, etc.), antibacterial preservatives such as hexachlorophene, glycine, alanine, valine, leucine, serine, threonine, phenylalanine,
Amino acids such as tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine, histidine and their alkali metal salts and hydrochlorides, acylsarcosinates (e.g. sodium lauroylcosinate), glutathione, citric acid, malic acid, tartaric acid, lactic acid, etc. Organic acids, vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B61-lipalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B12, vitamin B10 and its derivatives, ascorbic acid, ascorbic acid sulfate esters (salt), ascorbic acid phosphate ester (salt), vitamin C such as ascorbyl dipalmitate, α-tocopherol, β-
Tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin E nicotinate, vitamin D, vitamin H1, pantothenic acid, pantethine and other vitamins, nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizinic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalybutol, thymol, inositol, saponins (saikosaponin,
Various drugs such as carrot saponin, loofah sabonin, mucrodisaponin, etc.), pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, cephalanthine, placenta extract, Gishigishi, Clara, Kouhone, etc.
Organic solvents, alcohol, such as orange, sage, yarrow, mallow, Japanese stork, Japanese commonweed, thyme, horsetail, spruce, birch, horsetail, loofah, horse chestnut, saxifrage, arnica, lily, mugwort, peony, aloe, gardenia, Spanish mackerel, etc. Natural extracts, pigments extracted with polyhydric alcohol, water, aqueous alcohol, etc., sorbitan monolaurate, sorbitan monopalmidate, sorbitan sesquioleate, sorbitan oleate, polyoxyethylene sorbitan monolaurate, polyoxyethylene monostearate Nonionic surfactants such as sorbitan, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol diester, lauroyl jetanolamide, fatty acid isopropanolamide, maltitol hydroxy aliphatic ether, alkylated polysaccharide, alkyl glucoside, sugar ester, etc. agents, cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, laurylamine oxide, sodium palmitate,
Anionic surfactants, amphoteric surfactants such as sodium laurate, sodium lauryl sulfate, potassium lauryl sulfate, alkyl sulfate triethanolamine ether, funnel oil, linear dodecylbenzene sulfate, polyoxyethylene hydrogenated castor oil maleic acid, acylmethyl taurine, etc. ,
Flavors, purified water, etc. can be added. Further, the dosage form of the present invention may be arbitrary, for example, a solubilized system such as a lotion,
Emulsified products such as milky lotions and creams, or foundations,
It can take the form of a dispersion, ointment, etc.
エリスリトール及びイプシロンアミノカプロン酸の肌荒
れ防止、肌荒れ改善効果、紅斑などを発生させない、安
全性に優れたものであることを示すために、次の水分蒸
発速度による保湿効果の測定、ドデシル硫酸ナトリウム
開放塗布の刺激に対する肌荒れ防止作用の試験及び実使
用テストを行った。In order to demonstrate that erythritol and epsilon aminocaproic acid have an excellent effect on preventing and improving skin roughness, do not cause erythema, and are highly safe, we measured the moisturizing effect by the rate of water evaporation, and conducted open application of sodium dodecyl sulfate. Tests were conducted on the effect of preventing rough skin against irritation and practical use tests.
(水分蒸発速度による保湿効果の測定)保湿剤の保湿効
果を測定する試験としては、水分蒸発速度の測定が適し
ている。すなわち、2.OX 2.Ocmの濾紙上に1
0μmの試料液を滴下後、1分ごとにその重量減少を1
0分間測定し、1分当たりに減少する重量を求めた。な
お、保湿剤は、乾燥残分を水に5%の割合で溶かし試料
とした。対照としては、蒸留水を用いた。(Measurement of moisturizing effect by moisture evaporation rate) As a test for measuring the moisturizing effect of a humectant, measurement of the moisture evaporation rate is suitable. That is, 2. OX2. 1 on Ocm filter paper
After dropping a 0 μm sample solution, the weight decreases by 1 every minute.
The measurement was carried out for 0 minutes, and the weight that decreased per minute was determined. Note that a sample of the humectant was obtained by dissolving the dry residue in water at a ratio of 5%. Distilled water was used as a control.
判定方法は以下の通りである。The determination method is as follows.
一判定一
〇:水分蒸発速度 0,50μg/win、以下○:水
分蒸発速度 0.50〜0.55μg/sin。Judgment 10: Moisture evaporation rate 0.50 μg/win, below ○: Moisture evaporation rate 0.50 to 0.55 μg/sin.
△:水分蒸発速度 0.55−0.60 u g/ai
n。△: Moisture evaporation rate 0.55-0.60 ug/ai
n.
X:水分蒸発速度 0.60 u g/win、以上結
果を表−1に示した。X: Moisture evaporation rate 0.60 ug/win, the results are shown in Table-1.
エリスリトール及びグリセリンに強い保湿効果を認めた
。Erythritol and glycerin were found to have strong moisturizing effects.
(ドデシル硫酸ナトリウム開放塗布の刺激に対する肌荒
れ防止作用)
次に上記試験において保湿効果の高かった工りス7ノト
ール、グリセリン及び、イプシロンアミノカプロン酸、
エリスリトールとイプシロンアミノカプロン酸の混合試
料について、ドデシル硫酸ナトリウム開放塗布による刺
激に・対する肌荒れ防佳作用を試験した。(Skin roughness prevention effect against irritation caused by open application of sodium dodecyl sulfate) Next, we added 7-notol, glycerin, and epsilon aminocaproic acid, which had a high moisturizing effect in the above test.
A mixed sample of erythritol and epsilon aminocaproic acid was tested for its anti-irritation and skin roughening effect due to open application of sodium dodecyl sulfate.
すなわち、ハートレイ系アルピノモルモットC背部皮膚
を、3%のドデシル硫酸ナトリウム水溶液で処理し、肌
荒れを作製した。2時間後、各1度の試料を40μI開
放塗布した。これを5日間繰返し、68目に目視により
肌荒れ状態を測定した。That is, the back skin of Hartley Alpino guinea pig C was treated with a 3% aqueous solution of sodium dodecyl sulfate to create rough skin. After 2 hours, 40 μl of each sample was applied open. This was repeated for 5 days, and the state of rough skin was visually measured on the 68th day.
(以下余白) 一肌荒れ評点− 判定は該評点を基に10匹の平均値で行った。(Margin below) Rough skin rating - Judgment was made using the average value of 10 animals based on the scores.
−肌荒れ判定− 〇:評点の平均が4以上5以下 ○:評点の平均が3以上4未満 △;評点の平均が2以上3未満 ×:評点の平均が1以上2未満 結果を表−2に示した。-Rough skin determination- 〇: Average score is 4 or more and 5 or less ○: Average score is 3 or more and less than 4 △; Average score is 2 or more and less than 3 ×: Average score is 1 or more and less than 2 The results are shown in Table-2.
表−2
肌荒れ防止作用
以上のようにグリセリン、エリスリトールともに肌荒れ
防止作用を認めるが、グリセリンは高濃度になるとべた
つきがあり、皮膚表面上を閉塞するためか、かえって肌
荒れを増強する傾向がある。この作用が、高濃度のグリ
セリン配合皮膚外用剤の皮膚トラブルの原因になってい
ると考えられる。Table 2 Effect on preventing rough skin As mentioned above, both glycerin and erythritol have an effect on preventing rough skin, but glycerin is sticky at high concentrations and tends to increase rough skin, perhaps because it blocks the surface of the skin. This effect is thought to be the cause of skin troubles caused by external skin preparations containing high concentrations of glycerin.
一方、エリスリトールは、全ての濃度で肌荒れ防止作用
を認めた。また、これにイプシロンアミノカプロン酸を
加えるとこの効果は強くなった。On the other hand, erythritol was found to have an anti-skin effect at all concentrations. Furthermore, this effect was strengthened when epsilon aminocaproic acid was added.
し実施例]
次に実施例によって本発明をさらに詳細に説明する。な
お、本発明はこれにより限定されるものではない。EXAMPLES Next, the present invention will be explained in more detail with reference to Examples. Note that the present invention is not limited to this.
(実使用テスト) 実使用テストによる肌荒れ改善効果を以下に示す。(actual use test) The effect of improving rough skin in actual use tests is shown below.
一試験方法一
女性健康人(顔面)の皮膚表面形態をシリコーン樹脂に
よるレプリカ法を用いて肌のレプリカを採り顕微鏡(1
7倍)にて観察した。すなわち、皮紋の状態及び角層の
剥離状態から表−3に示す基準に基づいて肌荒れ評価1
.2と判断された者(肌荒れパネル)1群30名を用い
、顔面左右半々に処方例1及び比較例1のローション(
第1群)と処方例2及び比較例1のローション(第2群
)を1日2回塗布した。2週間後、再びレプリカを採り
肌の状態を観察し、前記同様、表−3に示す基準に従っ
て評価した。1 Test method 1 A replica of the skin surface of a healthy female person (facial) was taken using a silicone resin replica method and a microscope (1
Observation was made at 7x magnification. In other words, skin roughness rating 1 is based on the criteria shown in Table 3 based on the condition of the skin pattern and the peeling condition of the stratum corneum.
.. The lotions of Prescription Example 1 and Comparative Example 1 were applied to the left and right half of the face of 30 people in one group who were judged to have skin irritation of 2 (rough skin panel).
The lotions (Group 1) and Prescription Example 2 and Comparative Example 1 (Group 2) were applied twice a day. Two weeks later, a replica was taken again and the condition of the skin was observed and evaluated according to the criteria shown in Table 3 as above.
(以下余白) 表−3 判定は該評点をもとに下記の基準で行った。(Margin below) Table-3 Judgment was made using the following criteria based on the scores.
○:評点4及び5と評価されたパネルの割合が75%以
上
△:評点4及び5と評価きれたパネルの割合が25%以
上75%未満
×:評点4及び5と評価されたパネルの割合が25%未
満
ス]「匠ニーー乙
表−4の配合組成よりなるローションを常法により製造
した。○: The proportion of panels rated as 4 and 5 is 75% or more △: The proportion of panels rated as 4 and 5 is 25% or more and less than 75% ×: The proportion of panels rated as 4 and 5 <25%> Takumi - A lotion having the composition shown in Table 4 was manufactured by a conventional method.
比較例1
表−5の配合組成よりなるローションを常法により製造
した。Comparative Example 1 A lotion having the composition shown in Table 5 was manufactured by a conventional method.
表−5
表−4,5から明らかなように、本発明の皮膚外用剤は
肌荒れ改善効果に優れた新規な皮膚外用剤である。Table 5 As is clear from Tables 4 and 5, the skin external preparation of the present invention is a novel skin external preparation excellent in the effect of improving rough skin.
実施例3 パック 次の処方に従い常法によりパックを製造した。Example 3 Pack A pack was manufactured by a conventional method according to the following recipe.
カオリン 70.8タル
ク 23,0プロピレン
グリコール
酢酸カルシウム
尿素
エリスリトール
香料
5.0
0.01
0.5
0.3
0.39
実施例4 栄養クリーム
次の処方に従い常法により栄養り
した。Kaolin 70.8 Talc 23.0 Propylene Glycol Calcium Acetate Urea Erythritol Flavor 5.0 0.01 0.5 0.3 0.39 Example 4 Nutritional Cream Nourishing was carried out in a conventional manner according to the following formulation.
ステアリン酸 ステアリルアルコール 還元ラノリン スクワラン オクチルドデカノール マルチトールヒドロキシラウリル エーテル グリセリルモノステアレート 防腐剤 香料 プロピレングリコール リームを製造 2.0 7.0 2.0 5.0 6.0 3.0 2.0 適量 適量 5.0 エリスリトール 精製水 2.0 残余 実施例5 リップトリート 次の処方に従い常法によりリ ドを製造した。stearic acid stearyl alcohol reduced lanolin Squalane Octyldodecanol maltitol hydroxylauryl ether glyceryl monostearate Preservative fragrance Propylene glycol manufacture reams 2.0 7.0 2.0 5.0 6.0 3.0 2.0 Appropriate amount Appropriate amount 5.0 erythritol purified water 2.0 remainder Example 5 Lip treat Refill in the usual manner according to the following prescription. manufactured.
キャンデリラロウ 固形パラフィン ミツロウ カルナバロウ ラノリン ヒマシ油 エリスリトール イプシロンアミノカブロン酸 イソプロピルミリステート 香料 酸化防止剤 メント ップトリートメン 9.0 8.0 5.0 5.0 11.0 残余 18.0 10.0 10.0 適量 適量 実施例6 乳液 次の処方に従い常法により乳液を製造した。candelilla row solid paraffin Beeswax carnauba wax lanolin castor oil erythritol Epsilon aminocabronic acid isopropyl myristate fragrance Antioxidant ment top treatment 9.0 8.0 5.0 5.0 11.0 remainder 18.0 10.0 10.0 Appropriate amount Appropriate amount Example 6 Emulsion A milky lotion was prepared by a conventional method according to the following recipe.
ステアリン酸 セタノール ワセリン ラノリンアルコール 流動パラフィン スクワラン エス力ロール507 エリスリトール POE(10)モノオレート トリエタノールアミン プロピレングリコール 防腐剤 香料 精製水 2.0 1.0 3.0 2.0 8.0 2.0 2.0 10.0 2.5 1.0 5.0 適量 適量 残余 実施例7 乳液 次の処方に従い常法によ ステアリン酸 セタノール ワセリン り乳液を製造した。stearic acid Setanol Vaseline lanolin alcohol liquid paraffin Squalane S-power roll 507 erythritol POE (10) monooleate triethanolamine Propylene glycol Preservative fragrance purified water 2.0 1.0 3.0 2.0 8.0 2.0 2.0 10.0 2.5 1.0 5.0 Appropriate amount Appropriate amount remainder Example 7 Emulsion Follow the following recipe and use the usual method. stearic acid Setanol Vaseline A milky lotion was produced.
2.0 1.0 3.0 ラノリンアルコール 流動パラフィン スクワラン エス力ロール507 エリスリトール POE(10)モノオレート トリエタノールアミン プロピレングリコール 防腐剤 香料 精製水 2.0 8.0 2.0 2.0 25.0 2.5 1.0 5.0 適量 適量 残余 実施例8 乳液 次の処方に従い常法によ ステアリン酸 セタノール ワセリン ラノリンアルコール 流動パラフィン スクワラン り乳液を製造した。2.0 1.0 3.0 lanolin alcohol liquid paraffin Squalane S-power roll 507 erythritol POE (10) monooleate triethanolamine Propylene glycol Preservative fragrance purified water 2.0 8.0 2.0 2.0 25.0 2.5 1.0 5.0 Appropriate amount Appropriate amount remainder Example 8 Emulsion Follow the following recipe and use the usual method. stearic acid Setanol Vaseline lanolin alcohol liquid paraffin Squalane A milky lotion was produced.
2.0 1.0 3.0 2.0 8.0 2.0 エス力ロール507 エリスリトール イブシロンアミノカブロン酸 POE(10)モノオレート トリエタノールアミン プロピレングリコール 防腐剤 香料 精製水 2.0 5.0 3.0 2.5 1.0 5.0 適量 適量 残余 実施例9 栄養クリーム 次の処方に従い常法により栄養クリームを製造した。2.0 1.0 3.0 2.0 8.0 2.0 S-power roll 507 erythritol Ibsilone aminocabronic acid POE (10) monooleate triethanolamine Propylene glycol Preservative fragrance purified water 2.0 5.0 3.0 2.5 1.0 5.0 Appropriate amount Appropriate amount remainder Example 9 Nutritional cream A nutritional cream was produced by a conventional method according to the following recipe.
ステアリン酸 2.0ステア
リルアルコール 7.0還元ラノリン
2.0スクワラン
5.0オクチルドデカノール
6.0マルチトールヒドロキシラウリ
ル 3.0エーテル
グリセリルモノステアレート2.0
防腐剤 適量香料
適量プロピレングリコ
ール 5.0エリスリトール
1.0イプシロンアミノカプロン酸
0.5精製水
残余実施例10 バック
次の処方に従い常法によりバックを製造した。Stearic acid 2.0 Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane
5.0 octyldodecanol
6.0 Maltitol hydroxylauryl 3.0 Ether glyceryl monostearate 2.0 Preservatives Appropriate amount Fragrance
Appropriate amount of propylene glycol 5.0 erythritol
1.0 epsilon aminocaproic acid 0.5 purified water
Remaining Example 10 Bag A bag was manufactured by a conventional method according to the following recipe.
カオリン 65.0タルク
19.0プロピレン
グリコール 5.0酢酸カルシウム
0.01尿素
0.5エリスリトール
0.5イプシロンアミノカプロン酸0,
1
香料 0.39実施
例11 リップトリートメント次の処方に従い常法
によりリップトリートメントを製造した。Kaolin 65.0 Talc 19.0 Propylene Glycol 5.0 Calcium Acetate
0.01 urea
0.5 erythritol
0.5 epsilon aminocaproic acid 0,
1 Fragrance 0.39 Example 11 Lip Treatment A lip treatment was produced by a conventional method according to the following formulation.
キャンデリラロウ 9.0固形
パラフイン 8.0ミツロウ
5.0カルナバロウ
5.0ラノリン
11.Oヒマシ油
残余エリスリトール
20.0イプシロンアミノカプロン*
10.0イソプロピルミリステート10.0
香料 適量酸化防止剤
適量実施例3〜11の皮膚
外用剤は、肌荒れ防止、肌荒れ改善効果に優れ、丘疹、
面層、#庖、紅斑などを発生させない、安全性に優れた
皮膚外用剤であった。Candelilla wax 9.0 Solid paraffin 8.0 Beeswax
5.0 carnauba wax
5.0 lanolin
11. O castor oil
residual erythritol
20.0 Epsilon Amino Caprone *
10.0 Isopropyl myristate 10.0 Fragrance Appropriate amount Antioxidant Appropriate amount The skin external preparations of Examples 3 to 11 have excellent effects on preventing and improving rough skin, and are effective against papules,
It was a highly safe topical skin preparation that did not cause skin irritation, red spots, or erythema.
[発明の効果]
本発明の皮膚外用剤は肌荒れを改善し、皮膚に潤いと艶
を与える効果に優れ、
丘疹、
面層、
濃
庖、
紅斑などを発生させない安全性に優れた皮膚外用剤であ
る。[Effects of the Invention] The external skin preparation of the present invention is a highly safe external skin preparation that improves rough skin, provides moisture and luster to the skin, and does not cause papules, superficial layers, thickening, or erythema. be.
Claims (2)
外用剤。(1) A skin external preparation characterized by containing erythritol.
を配合することを特徴とする皮膚外用剤。(2) A skin external preparation characterized by containing erythritol and epsilon aminocaproic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2245185A JP2594173B2 (en) | 1990-09-14 | 1990-09-14 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2245185A JP2594173B2 (en) | 1990-09-14 | 1990-09-14 | External preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04124118A true JPH04124118A (en) | 1992-04-24 |
JP2594173B2 JP2594173B2 (en) | 1997-03-26 |
Family
ID=17129879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2245185A Expired - Lifetime JP2594173B2 (en) | 1990-09-14 | 1990-09-14 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2594173B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07215838A (en) * | 1994-02-04 | 1995-08-15 | Shiseido Co Ltd | Skin external agent |
JPH08109122A (en) * | 1994-10-07 | 1996-04-30 | Kanebo Ltd | Skin cosmetic |
US6340677B1 (en) | 1997-03-11 | 2002-01-22 | Pola Chemical Industries, Inc. | Method of evaluation of skin conditioning-ameliorating agents and method of producing compositions for topical application to skin |
JP2008074761A (en) * | 2006-09-20 | 2008-04-03 | Naris Cosmetics Co Ltd | Cosmetic |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS627A (en) * | 1985-03-04 | 1987-01-06 | Shiseido Co Ltd | Skin external agent containing incorporated urea |
JPH0193509A (en) * | 1987-10-02 | 1989-04-12 | Shiseido Co Ltd | Skin drug for external use |
JPH0272106A (en) * | 1988-04-25 | 1990-03-12 | L'oreal Sa | Makeup cosmetic composition containing fine globules of crosslinked poly-beta-alanine impregnated with polyhydric alcohol |
-
1990
- 1990-09-14 JP JP2245185A patent/JP2594173B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS627A (en) * | 1985-03-04 | 1987-01-06 | Shiseido Co Ltd | Skin external agent containing incorporated urea |
JPH0193509A (en) * | 1987-10-02 | 1989-04-12 | Shiseido Co Ltd | Skin drug for external use |
JPH0272106A (en) * | 1988-04-25 | 1990-03-12 | L'oreal Sa | Makeup cosmetic composition containing fine globules of crosslinked poly-beta-alanine impregnated with polyhydric alcohol |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07215838A (en) * | 1994-02-04 | 1995-08-15 | Shiseido Co Ltd | Skin external agent |
JPH08109122A (en) * | 1994-10-07 | 1996-04-30 | Kanebo Ltd | Skin cosmetic |
US6340677B1 (en) | 1997-03-11 | 2002-01-22 | Pola Chemical Industries, Inc. | Method of evaluation of skin conditioning-ameliorating agents and method of producing compositions for topical application to skin |
JP3408258B2 (en) * | 1997-03-11 | 2003-05-19 | ポーラ化成工業株式会社 | Method for evaluating skin condition improving agent and method for producing external preparation for skin |
JP2008074761A (en) * | 2006-09-20 | 2008-04-03 | Naris Cosmetics Co Ltd | Cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JP2594173B2 (en) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3483988B2 (en) | Skin preparation | |
DE69623914T2 (en) | EXTERNAL SKIN PREPARATION | |
JP3344822B2 (en) | External preparation for skin | |
JP3122167B2 (en) | Artemisia extract and use thereof | |
US6214352B1 (en) | Tyrosinase inhibiting agent | |
JP2007254412A (en) | External preparation for skin for prevention and/or improvement of wrinkles | |
JPH07215838A (en) | Skin external agent | |
KR101361430B1 (en) | Skin external preparation having excellent stability | |
JP3807926B2 (en) | Topical skin preparation containing ascorbic acid | |
JPH04124118A (en) | Skin external preparation | |
JPH07215839A (en) | Skin external agent | |
JP2001039854A (en) | Skin preparation for external use | |
JP5068091B2 (en) | Emulsifier type skin external preparation | |
JP2003081741A (en) | Skin care preparation | |
JP2005132828A (en) | Composition for external application | |
JP3119622B2 (en) | Cosmetics | |
JP2004010505A (en) | Cosmetic | |
JPH09263514A (en) | Preparation for external use for skin | |
JPH04169526A (en) | Skin external medicine | |
JPH10273413A (en) | Skin preparation for external use | |
JPH07215832A (en) | Skin external preparation | |
JP2720247B2 (en) | External preparation for skin | |
JPH05112442A (en) | External preparation of skin | |
JPH115725A (en) | Preparation for external use for skin | |
JPH08268866A (en) | Dermal preparation for external use |